Yingdi Zhang
Guiyang Medical University(CN)Shenzhen University(CN)
Publications by Year
Research Areas
Gut microbiota and health, Inflammatory Bowel Disease, MicroRNA in disease regulation, Probiotics and Fermented Foods, Helicobacter pylori-related gastroenterology studies
Most-Cited Works
- → miR-19b downregulates intestinal SOCS3 to reduce intestinal inflammation in Crohn’s disease(2015)74 cited
- → Probiotic Mixture Protects Dextran Sulfate Sodium-Induced Colitis by Altering Tight Junction Protein Expressions and Increasing Tregs(2018)53 cited
- → A selective HPLC method for the determination of indapamide in human whole blood: Application to a bioequivalence study in Chinese volunteers(2005)24 cited
- → Picroside III Ameliorates Colitis in Mice: A Study Based on Colon Transcriptome and Fecal 16S Amplicon Profiling(2023)2 cited
- → miRNA-19b regulates proliferation of human colon cancer cell line HT-29(2015)1 cited
- → Mo1320: GUT MICROBIOTA-DERIVED LITHOCHOLIC ACID LEADS TO INTESTINAL BARRIER DYSFUNCTION VIA LPCAT1 IN IRRITABLE BOWEL SYNDROME(2025)1 cited
- → Gut microbiota-derived lithocholic acid leads to intestinal barrier dysfunction via LPCAT1 in irritable bowel syndrome(2025)
- → Cover Picture: Picroside III Ameliorates Colitis in Mice: A Study Based on Colon Transcriptome and Fecal 16S Amplicon Profiling (Chem. Biodiversity 12/2023)(2023)
- Human relative bioavailability of mecobalamin tablets(2006)
- → 6-Feruloylcatalpol inhibits Th17 response in colitis by mediating the P2Y1R/AMPK signaling(2025)